CII vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CII exhibits a stable financial profile with a Piotroski F-Score of 6/9 and no debt, indicating solid operational health. The asset is severely undervalued, trading at $23.77 despite a Graham Number of $50.85 and an intrinsic value estimate of $149.86. With an exceptionally low P/E of 4.68 and a strong dividend yield of 7.12%, the fund offers significant value and income potential. While the technical trend score is listed as bearish, the actual 1-year price performance of +55.4% suggests strong underlying momentum.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
CII vs JPM: Head-to-Head Comparison
This page compares BlackRock Enhanced Large Cap Core Fund, Inc. (CII) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.